Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD69 | Q07108 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | PYGB | P11216 | 2/20 | 0.42 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | SLC28A3 | Q9HAS3 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 2/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | PRKCG | P05129 | 1/20 | 0.38 |
| ▸ | PRKCB | P05771 | 1/20 | 0.38 |
| ▸ | PRKCH | P24723 | 1/20 | 0.38 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.38 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.38 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16683389 | 1.00 | CD69 (0.53) | CD69MAPK1PYGBLGALS8KDM4E | |
| SCHEMBL2429109 | 1.00 | CD69 (0.53) | CD69MAPK1PYGBLGALS8KDM4E | |
| SCHEMBL8021265 | 1.00 | CD69 (0.53) | CD69MAPK1PYGBLGALS8KDM4E | |
| SCHEMBL6268182 | 1.00 | CD69 (0.53) | CD69MAPK1PYGBLGALS8KDM4E | |
| SCHEMBL8166277 | 1.00 | CD69 (0.53) | CD69MAPK1PYGBLGALS8KDM4E | |
| SCHEMBL8361872 | 1.00 | CD69 (0.53) | CD69MAPK1PYGBLGALS8KDM4E | |
| SCHEMBL14414822 | 0.95 | CD69 (0.48) | CD69MAPK1PYGBLGALS8KDM4E | |
| SCHEMBL6936528 | 0.95 | CD69 (0.48) | CD69MAPK1PYGBLGALS8KDM4E | |
| SCHEMBL10022858 | 0.89 | CD69 (0.47) | CD69MAPK1PYGBLGALS8KDM4E | |
| SCHEMBL16260821 | 0.89 | CD69 (0.47) | CD69MAPK1PYGBLGALS8KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240083933-A1 | DISACCHARIDES FOR TREATING BONE DISEASES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-03-14 | — | — | US | disclosed |
| EP-1017683-A4 | PROTECTING AND LINKING GROUPS FOR ORGANIC SYNTHESIS | ALCHEMIA PTY LTD (AU) | 2002-03-06 | — | — | EP | disclosed |
| EP-1017683-A1 | PROTECTING AND LINKING GROUPS FOR ORGANIC SYNTHESIS | Alchemia Pty. Ltd. (AU) | 2000-07-12 | — | — | EP | disclosed |
| WO-1999015510-A1 | PROTECTING AND LINKING GROUPS FOR ORGANIC SYNTHESIS | ALCHEMIA PTY. LTD. (AU) | 1999-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240083933-A1 | DISACCHARIDES FOR TREATING BONE DISEASES | SLC9A3, HEXD, SOST | CD69 1091/4885MAPK1 651/4885PYGB 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.